期刊文献+

应用实时荧光PCR方法检测乙型肝炎病毒基因YMDD变异 被引量:1

Applicate method of real time PCR to detect YMDD variation in HBV
下载PDF
导出
摘要 [目的]建立一种检测乙型肝炎患者YMDD变异株的方法,并且研究应用拉米夫定治疗及未用药治疗的乙型肝炎初发患者中YMDD变异株发生的情况。[方法]应用实时荧光聚合酶链反应(PCR)方法对30例未经过任何药物治疗的乙肝初发患者,50例使用拉米夫定治疗1年患者,50例使用拉米夫定治疗两年患者和20例使用拉米夫定与干扰素联合治疗两年的患者同时进行YMDD变异株的检测。[结果]通过对熔解曲线的分析,在未经任何治疗的乙肝初发患者中检出YMDD变异株2例,占6.67%;拉米夫定治疗1年的患者中检出YMDD变异株13例,占26.00%;拉米夫定治疗两年患者中检出YMDD变异株25例,占50.00%;拉米夫定和干扰素联合治疗的患者中检出YMDD变异株9例,占45.00%。[结论]在未经任何药物治疗的乙肝患者中即存在YMDD变异株,并且随着使用拉米夫定时间的延长在不断增加,且联合用药并不能减少变异株的发生,因此对乙肝患者在用药前,及用药过程中进行YMDD变异株的检测是非常必要的。而实时荧光PCR方法具有简便、快速、灵敏、经济的特点,特别适用于临床对YMDD变异株的检测,从而及时的指导临床用药。 [ Objective] Setting up a method to detect YMDD mutation during lamivudine therapy and study the application pull the rice man settles the treatment and did not use the initial stages in hepatitis in type in B of the medicine treatment the sufferer the circumstance of the inside YMDD variation stub occurrence, [ Methods] The application comes together with the real time PCR method to the early hair in liver in B for having not yet any medicine treatment sufferer,50 usages pulls the rice man settles the sufferer who cure a year,50 usages pulls the sufferer that rice man settle two years in treatment to pull with 20 usages the rice man settle with the intederon sufferer of uniting two years in treatment at the same time the examination that proceed the YMDD variation stub. [Results ] Pass to solve the curvilinear analysis to the liquate linear , examine the 2 examples :YMDD variation stub in earlier in liver in B that had not yet any treatment sufferer, occupy 6,67% ;Pulling the rice man settle the sufferer who cure to examine the 13 examples :YMDD variation stub in a year, occupying 26, 00% ; Pulling the rice man settles two years in treatment to examine the 25 examples : YMDD variation stub in the sufferer, occupying 50, 00%, pulling the rice man settle to examine the 9 examples : YMDD variation stub with interferon in the sufferer of uniting the treatment, occupying 45, 00%. [ Conclusion] Exsits namely in had not yet any medicine treatment of B liver sufferer YMDD variation stub, and pull along with the usage the rice man settles the horary extension at increase continuously, and in association with use the medicine and cant reduce the occurrence of the variation stub, therefore to B liver the sufferer proceeds in use medicine front, and use medicine process the YMDD variation stub examination is very necessary, The method described here provides a convenient,rapid ,accurate and inexpensive way to monitor YMDD mutation during lamivudine therapy.
出处 《大连医科大学学报》 CAS 2007年第1期70-73,共4页 Journal of Dalian Medical University
关键词 乙型肝炎病毒 聚合酶链反应 变异 YMDD hpatitis B virus polymerase chain reaction variation YMDD
  • 相关文献

参考文献10

  • 1Stuyver , Van Get V , De Gendt S , et al. Line probe for monitoring drug resistance in hepatitis B patients during antiviral therapy [ J]. Clin Microbiol,2000,38:702 - 707.
  • 2崔儒涛,王宝恩,张福奎,尹珊珊.拉米夫定治疗相关的乙型肝炎病毒变异研究进展[J].中华肝脏病杂志,2002,10(3):238-240. 被引量:21
  • 3Gutfreund KS, Williams M, George R, et al. Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance[ J]. HePatol,2000,33: 469 - 475.
  • 4Doo E, Liang TJ, Molecular anatomy and Pathophysiologic implications of drug resistance in hepatitis B virus infection [J]. Gastroenterology,2001,120 : 1000 - 1008.
  • 5StuyVer LJ, Locamin SA, Lok A, et al. NomenClature for antiviral - Tesistaflt human hepatitis B virus mutation in the polymerase region [J]. Hepatology,2001,33 :751 - 757.
  • 6Liaw YF, Chlen RN, Yeh CT, et al. Acute exacerhation and hepatitis, B virus clearance after emergence of YMDD motif mutation during lamivudine therapy [J]. Hepatology, 1999, 30:567 - 572.
  • 7Buti M, Sanchez F, Cotrina M. et al. Quantitative hepatitis B virus DNA testing for the early Prediction of the maintenance of response during lamivudine therapy in Patients with chronic hepatitis B[J]. Infect Dis,2001, 183:1277 - 1280.
  • 8Yeh CT,Chien RN,Chu CM,et al. clearance of the original hepatitis B virus YMDD - motif mutants with emergence of distinct lamivudine - resistant mutants during Prolonged lamivudine therapy [ J ]. Hepatology, 2000, 31 : 1318 - 1326.
  • 9王海滨,姜平,马洪滨,王雪飞,鞠连才,徐军,杨丽华,刘立明,李波,李潇潇.乙型肝炎病毒YMDD变异与肝功能损伤程度的关系[J].中华检验医学杂志,2005,28(9):922-924. 被引量:10
  • 10赵伟,刘伟,刘全俊,张林,张汉荣,刘新珏,周镇先.基因芯片检测拉米夫定治疗慢性乙型肝炎过程中HBV变异技术的建立和应用[J].中华实验和临床病毒学杂志,2003,17(4):339-343. 被引量:3

二级参考文献16

  • 1Ramsay G.DNA chips:state of the art[J],1998(1).
  • 2Schena M;Shalon D;Davis RW.Quantitative monitoring of gene expression patterns with a complementary DNA microarray[J],1995(5235).
  • 3Villeneuve JP;Condreay LD;Willems B.Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B[J],2000(1).
  • 4Marshall A;Hodgson J.DNA chips: an array of possibilities[J],1998(1).
  • 5Buti M;Cotrian M;Cruz de Castro E.One year treatment with lamivudine in different hepatitis B virus related hepatic disease,1999.
  • 6Sokal EM;Roberts EA;Mieli-Vergani G.A dose ranging study of the pharmacokineties,safety, and preliminary efficacy of lamivudine in children and adolescents with chronic hepatitis B[J],2000.
  • 7Editoral.Hepatitis B therapy:the plot thickens[J],1999(2).
  • 8Dienstag JL;Schiff ER;Wright TL.Lamivudine as initial treatment for chronic hepatitis B in the United States[J],1999.
  • 9姚光弼,王宝恩,崔振宇,姚集鲁,曾明德.拉米夫定治疗慢性乙型肝炎病人的长期疗效[J].中华肝脏病杂志,1999,7(2):80-83. 被引量:347
  • 10拉米夫定临床应用专家指导小组.2000年拉米夫定临床应用指导意见[J].中华肝脏病杂志,2000,8(4):249-250. 被引量:114

共引文献31

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部